Pharmacokinetics in children with chronic kidney disease
In children, the main causes of chronic kidney disease (CKD) are congenital diseases and glomerular disorders. CKD is associated with multiple physiological changes and may therefore influence various pharmacokinetic (PK) parameters. A well-known consequence of CKD on pharmacokinetics is a reduction...
Gespeichert in:
| Veröffentlicht in: | Pediatric nephrology (Berlin, West) West), 2020-07, Vol.35 (7), p.1153-1172 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 1172 |
|---|---|
| container_issue | 7 |
| container_start_page | 1153 |
| container_title | Pediatric nephrology (Berlin, West) |
| container_volume | 35 |
| creator | Schijvens, Anne M. de Wildt, Saskia N. Schreuder, Michiel F. |
| description | In children, the main causes of chronic kidney disease (CKD) are congenital diseases and glomerular disorders. CKD is associated with multiple physiological changes and may therefore influence various pharmacokinetic (PK) parameters. A well-known consequence of CKD on pharmacokinetics is a reduction in renal clearance due to a decrease in the glomerular filtration rate. The impact of renal impairment on pharmacokinetics is, however, not limited to a decreased elimination of drugs excreted by the kidney. In fact, renal dysfunction may lead to modifications in absorption, distribution, transport, and metabolism as well. Currently, insufficient evidence is available to guide dosing decisions on many commonly used drugs. Moreover, the impact of maturation on drug disposition and action should be taken into account when selecting and dosing drugs in the pediatric population. Clinicians should take PK changes into consideration when selecting and dosing drugs in pediatric CKD patients in order to avoid toxicity and increase efficiency of drugs in this population. The aim of this review is to summarize known PK changes in relation to CKD and to extrapolate available knowledge to the pediatric CKD population to provide guidance for clinical practice. |
| doi_str_mv | 10.1007/s00467-019-04304-9 |
| format | Article |
| fullrecord | <record><control><sourceid>gale_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7248054</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A624898469</galeid><sourcerecordid>A624898469</sourcerecordid><originalsourceid>FETCH-LOGICAL-c610t-e16b76b7014d5e9a45fd78b20d238f2c2c97ffe3365c453745665bbe0c89899e3</originalsourceid><addsrcrecordid>eNp9kltrFTEUhYMo9lj9Az7IgODb1NwvL0Ip3qBgHyr0LWQye86knUlqMqfSf2_qqW0PHCSBsLO_tRI2C6G3BB8RjNXHgjGXqsXEtJgzzFvzDK0IZ7QlRl88RytsGKktcnGAXpVyiTHWQsuX6IARpoQhbIX02ejy7Hy6ChGW4EsTYuPHMPUZYvM7LGOtcorBN1ehj3Db9KGAK_AavRjcVODN_XmIfn75fH7yrT398fX7yfFp6yXBSwtEdqpuTHgvwDguhl7pjuKeMj1QT71RwwCMSeG5YIoLKUXXAfbaaGOAHaJPW9_rTTdD7yEu2U32OofZ5VubXLC7nRhGu043VlGuseDV4P29QU6_NlAWe5k2OdY_W0qlMkZJpR6ptZvAhjikaubnULw9ltXJaC5Npdo91Boi1JdThCHU6x3-aA9fVw9z8HsFH54IRnDTMpY0bZaQYtkF6Rb0OZWSYXiYCMH2Lh12mw5b02H_psPeid49neWD5F8cKsC2QKmtuIb8OKv_2P4BkKzDAQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2267997677</pqid></control><display><type>article</type><title>Pharmacokinetics in children with chronic kidney disease</title><source>MEDLINE</source><source>SpringerLink Journals</source><creator>Schijvens, Anne M. ; de Wildt, Saskia N. ; Schreuder, Michiel F.</creator><creatorcontrib>Schijvens, Anne M. ; de Wildt, Saskia N. ; Schreuder, Michiel F.</creatorcontrib><description>In children, the main causes of chronic kidney disease (CKD) are congenital diseases and glomerular disorders. CKD is associated with multiple physiological changes and may therefore influence various pharmacokinetic (PK) parameters. A well-known consequence of CKD on pharmacokinetics is a reduction in renal clearance due to a decrease in the glomerular filtration rate. The impact of renal impairment on pharmacokinetics is, however, not limited to a decreased elimination of drugs excreted by the kidney. In fact, renal dysfunction may lead to modifications in absorption, distribution, transport, and metabolism as well. Currently, insufficient evidence is available to guide dosing decisions on many commonly used drugs. Moreover, the impact of maturation on drug disposition and action should be taken into account when selecting and dosing drugs in the pediatric population. Clinicians should take PK changes into consideration when selecting and dosing drugs in pediatric CKD patients in order to avoid toxicity and increase efficiency of drugs in this population. The aim of this review is to summarize known PK changes in relation to CKD and to extrapolate available knowledge to the pediatric CKD population to provide guidance for clinical practice.</description><identifier>ISSN: 0931-041X</identifier><identifier>EISSN: 1432-198X</identifier><identifier>DOI: 10.1007/s00467-019-04304-9</identifier><identifier>PMID: 31375913</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Age Factors ; Animals ; Child ; Children ; Chronic kidney failure ; Complications and side effects ; Dose-Response Relationship, Drug ; Drug dosages ; Drug therapy ; Glomerular filtration rate ; Glomerular Filtration Rate - drug effects ; Humans ; Kidney diseases ; Liver - metabolism ; Medicine ; Medicine & Public Health ; Nephrology ; Pediatric research ; Pediatrics ; Pharmacokinetics ; Rats ; Renal function ; Renal Insufficiency, Chronic - physiopathology ; Review ; Toxicity ; Urology ; What’s New in Chronic Kidney Disease</subject><ispartof>Pediatric nephrology (Berlin, West), 2020-07, Vol.35 (7), p.1153-1172</ispartof><rights>The Author(s) 2019</rights><rights>COPYRIGHT 2020 Springer</rights><rights>The Author(s) 2019. This work is published under https://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c610t-e16b76b7014d5e9a45fd78b20d238f2c2c97ffe3365c453745665bbe0c89899e3</citedby><cites>FETCH-LOGICAL-c610t-e16b76b7014d5e9a45fd78b20d238f2c2c97ffe3365c453745665bbe0c89899e3</cites><orcidid>0000-0003-2418-8928</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00467-019-04304-9$$EPDF$$P50$$Gspringer$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00467-019-04304-9$$EHTML$$P50$$Gspringer$$Hfree_for_read</linktohtml><link.rule.ids>230,314,780,784,885,27924,27925,41488,42557,51319</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/31375913$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Schijvens, Anne M.</creatorcontrib><creatorcontrib>de Wildt, Saskia N.</creatorcontrib><creatorcontrib>Schreuder, Michiel F.</creatorcontrib><title>Pharmacokinetics in children with chronic kidney disease</title><title>Pediatric nephrology (Berlin, West)</title><addtitle>Pediatr Nephrol</addtitle><addtitle>Pediatr Nephrol</addtitle><description>In children, the main causes of chronic kidney disease (CKD) are congenital diseases and glomerular disorders. CKD is associated with multiple physiological changes and may therefore influence various pharmacokinetic (PK) parameters. A well-known consequence of CKD on pharmacokinetics is a reduction in renal clearance due to a decrease in the glomerular filtration rate. The impact of renal impairment on pharmacokinetics is, however, not limited to a decreased elimination of drugs excreted by the kidney. In fact, renal dysfunction may lead to modifications in absorption, distribution, transport, and metabolism as well. Currently, insufficient evidence is available to guide dosing decisions on many commonly used drugs. Moreover, the impact of maturation on drug disposition and action should be taken into account when selecting and dosing drugs in the pediatric population. Clinicians should take PK changes into consideration when selecting and dosing drugs in pediatric CKD patients in order to avoid toxicity and increase efficiency of drugs in this population. The aim of this review is to summarize known PK changes in relation to CKD and to extrapolate available knowledge to the pediatric CKD population to provide guidance for clinical practice.</description><subject>Age Factors</subject><subject>Animals</subject><subject>Child</subject><subject>Children</subject><subject>Chronic kidney failure</subject><subject>Complications and side effects</subject><subject>Dose-Response Relationship, Drug</subject><subject>Drug dosages</subject><subject>Drug therapy</subject><subject>Glomerular filtration rate</subject><subject>Glomerular Filtration Rate - drug effects</subject><subject>Humans</subject><subject>Kidney diseases</subject><subject>Liver - metabolism</subject><subject>Medicine</subject><subject>Medicine & Public Health</subject><subject>Nephrology</subject><subject>Pediatric research</subject><subject>Pediatrics</subject><subject>Pharmacokinetics</subject><subject>Rats</subject><subject>Renal function</subject><subject>Renal Insufficiency, Chronic - physiopathology</subject><subject>Review</subject><subject>Toxicity</subject><subject>Urology</subject><subject>What’s New in Chronic Kidney Disease</subject><issn>0931-041X</issn><issn>1432-198X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>C6C</sourceid><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNp9kltrFTEUhYMo9lj9Az7IgODb1NwvL0Ip3qBgHyr0LWQye86knUlqMqfSf2_qqW0PHCSBsLO_tRI2C6G3BB8RjNXHgjGXqsXEtJgzzFvzDK0IZ7QlRl88RytsGKktcnGAXpVyiTHWQsuX6IARpoQhbIX02ejy7Hy6ChGW4EsTYuPHMPUZYvM7LGOtcorBN1ehj3Db9KGAK_AavRjcVODN_XmIfn75fH7yrT398fX7yfFp6yXBSwtEdqpuTHgvwDguhl7pjuKeMj1QT71RwwCMSeG5YIoLKUXXAfbaaGOAHaJPW9_rTTdD7yEu2U32OofZ5VubXLC7nRhGu043VlGuseDV4P29QU6_NlAWe5k2OdY_W0qlMkZJpR6ptZvAhjikaubnULw9ltXJaC5Npdo91Boi1JdThCHU6x3-aA9fVw9z8HsFH54IRnDTMpY0bZaQYtkF6Rb0OZWSYXiYCMH2Lh12mw5b02H_psPeid49neWD5F8cKsC2QKmtuIb8OKv_2P4BkKzDAQ</recordid><startdate>20200701</startdate><enddate>20200701</enddate><creator>Schijvens, Anne M.</creator><creator>de Wildt, Saskia N.</creator><creator>Schreuder, Michiel F.</creator><general>Springer Berlin Heidelberg</general><general>Springer</general><general>Springer Nature B.V</general><scope>C6C</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QP</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AZQEC</scope><scope>BENPR</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>K9-</scope><scope>K9.</scope><scope>KB0</scope><scope>M0R</scope><scope>M0S</scope><scope>M1P</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0003-2418-8928</orcidid></search><sort><creationdate>20200701</creationdate><title>Pharmacokinetics in children with chronic kidney disease</title><author>Schijvens, Anne M. ; de Wildt, Saskia N. ; Schreuder, Michiel F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c610t-e16b76b7014d5e9a45fd78b20d238f2c2c97ffe3365c453745665bbe0c89899e3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Age Factors</topic><topic>Animals</topic><topic>Child</topic><topic>Children</topic><topic>Chronic kidney failure</topic><topic>Complications and side effects</topic><topic>Dose-Response Relationship, Drug</topic><topic>Drug dosages</topic><topic>Drug therapy</topic><topic>Glomerular filtration rate</topic><topic>Glomerular Filtration Rate - drug effects</topic><topic>Humans</topic><topic>Kidney diseases</topic><topic>Liver - metabolism</topic><topic>Medicine</topic><topic>Medicine & Public Health</topic><topic>Nephrology</topic><topic>Pediatric research</topic><topic>Pediatrics</topic><topic>Pharmacokinetics</topic><topic>Rats</topic><topic>Renal function</topic><topic>Renal Insufficiency, Chronic - physiopathology</topic><topic>Review</topic><topic>Toxicity</topic><topic>Urology</topic><topic>What’s New in Chronic Kidney Disease</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Schijvens, Anne M.</creatorcontrib><creatorcontrib>de Wildt, Saskia N.</creatorcontrib><creatorcontrib>Schreuder, Michiel F.</creatorcontrib><collection>Springer Nature OA Free Journals</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central Essentials</collection><collection>ProQuest Central</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>Consumer Health Database (Alumni Edition)</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Consumer Health Database</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Pediatric nephrology (Berlin, West)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Schijvens, Anne M.</au><au>de Wildt, Saskia N.</au><au>Schreuder, Michiel F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Pharmacokinetics in children with chronic kidney disease</atitle><jtitle>Pediatric nephrology (Berlin, West)</jtitle><stitle>Pediatr Nephrol</stitle><addtitle>Pediatr Nephrol</addtitle><date>2020-07-01</date><risdate>2020</risdate><volume>35</volume><issue>7</issue><spage>1153</spage><epage>1172</epage><pages>1153-1172</pages><issn>0931-041X</issn><eissn>1432-198X</eissn><abstract>In children, the main causes of chronic kidney disease (CKD) are congenital diseases and glomerular disorders. CKD is associated with multiple physiological changes and may therefore influence various pharmacokinetic (PK) parameters. A well-known consequence of CKD on pharmacokinetics is a reduction in renal clearance due to a decrease in the glomerular filtration rate. The impact of renal impairment on pharmacokinetics is, however, not limited to a decreased elimination of drugs excreted by the kidney. In fact, renal dysfunction may lead to modifications in absorption, distribution, transport, and metabolism as well. Currently, insufficient evidence is available to guide dosing decisions on many commonly used drugs. Moreover, the impact of maturation on drug disposition and action should be taken into account when selecting and dosing drugs in the pediatric population. Clinicians should take PK changes into consideration when selecting and dosing drugs in pediatric CKD patients in order to avoid toxicity and increase efficiency of drugs in this population. The aim of this review is to summarize known PK changes in relation to CKD and to extrapolate available knowledge to the pediatric CKD population to provide guidance for clinical practice.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><pmid>31375913</pmid><doi>10.1007/s00467-019-04304-9</doi><tpages>20</tpages><orcidid>https://orcid.org/0000-0003-2418-8928</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0931-041X |
| ispartof | Pediatric nephrology (Berlin, West), 2020-07, Vol.35 (7), p.1153-1172 |
| issn | 0931-041X 1432-198X |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7248054 |
| source | MEDLINE; SpringerLink Journals |
| subjects | Age Factors Animals Child Children Chronic kidney failure Complications and side effects Dose-Response Relationship, Drug Drug dosages Drug therapy Glomerular filtration rate Glomerular Filtration Rate - drug effects Humans Kidney diseases Liver - metabolism Medicine Medicine & Public Health Nephrology Pediatric research Pediatrics Pharmacokinetics Rats Renal function Renal Insufficiency, Chronic - physiopathology Review Toxicity Urology What’s New in Chronic Kidney Disease |
| title | Pharmacokinetics in children with chronic kidney disease |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-04T17%3A56%3A17IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Pharmacokinetics%20in%20children%20with%20chronic%20kidney%20disease&rft.jtitle=Pediatric%20nephrology%20(Berlin,%20West)&rft.au=Schijvens,%20Anne%20M.&rft.date=2020-07-01&rft.volume=35&rft.issue=7&rft.spage=1153&rft.epage=1172&rft.pages=1153-1172&rft.issn=0931-041X&rft.eissn=1432-198X&rft_id=info:doi/10.1007/s00467-019-04304-9&rft_dat=%3Cgale_pubme%3EA624898469%3C/gale_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2267997677&rft_id=info:pmid/31375913&rft_galeid=A624898469&rfr_iscdi=true |